73 related articles for article (PubMed ID: 38444739)
21. Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research.
Liu Q; Palmgren VAC; Danen EH; Le Dévédec SE
Mol Biol Rep; 2022 Nov; 49(11):10961-10973. PubMed ID: 36057753
[TBL] [Abstract][Full Text] [Related]
22. Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.
Miller JL; Bartlett AP; Harman RM; Majhi PD; Jerry DJ; Van de Walle GR
J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):185-210. PubMed ID: 35904679
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation.
Mills JA; Liu F; Jarrett TR; Fletcher NL; Thurecht KJ
Biomater Sci; 2022 Jun; 10(12):3029-3053. PubMed ID: 35419582
[TBL] [Abstract][Full Text] [Related]
24. The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge.
Coles CE; Anderson BO; Cameron D; Cardoso F; Horton R; Knaul FM; Mutebi M; Lee N;
Lancet; 2022 Mar; 399(10330):1101-1103. PubMed ID: 35189077
[No Abstract] [Full Text] [Related]
25. Drug release study of the chitosan-based nanoparticles.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Heliyon; 2022 Jan; 8(1):e08674. PubMed ID: 35028457
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma.
Mudigunda SV; Pemmaraju DB; Paradkar S; Puppala ER; Gawali B; Upadhyayula SM; Vegi Gangamodi N; Rengan AK
ACS Biomater Sci Eng; 2022 Jan; 8(1):151-160. PubMed ID: 34933546
[TBL] [Abstract][Full Text] [Related]
27. Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment.
Vikas ; Viswanadh MK; Mehata AK; Sharma V; Priya V; Varshney N; Mahto SK; Muthu MS
Carbohydr Polym; 2021 Nov; 274():118617. PubMed ID: 34702448
[TBL] [Abstract][Full Text] [Related]
28. Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival.
Toft NJ; Axelsen TV; Pedersen HL; Mele M; Burton M; Balling E; Johansen T; Thomassen M; Christiansen PM; Boedtkjer E
Elife; 2021 Jul; 10():. PubMed ID: 34219652
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia in Breast Cancer-Scientific Translation to Therapeutic and Diagnostic Clinical Applications.
Zhang Y; Zhang H; Wang M; Schmid T; Xin Z; Kozhuharova L; Yu WK; Huang Y; Cai F; Biskup E
Front Oncol; 2021; 11():652266. PubMed ID: 33777815
[TBL] [Abstract][Full Text] [Related]
30. Chitosan and crosslinked chitosan nanoparticles: Synthesis, characterization and their role as Pickering emulsifiers.
Ribeiro EF; de Barros-Alexandrino TT; Assis OBG; Junior AC; Quiles A; Hernando I; Nicoletti VR
Carbohydr Polym; 2020 Dec; 250():116878. PubMed ID: 33049877
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-Responsive, Polymeric Nanocarriers for Targeted Drug Delivery to Estrogen Receptor-Positive Breast Cancer Cell Spheroids.
Mamnoon B; Feng L; Froberg J; Choi Y; Sathish V; Mallik S
Mol Pharm; 2020 Nov; 17(11):4312-4322. PubMed ID: 32926627
[TBL] [Abstract][Full Text] [Related]
32. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
Kurmi BD; Paliwal R; Paliwal SR
Int J Biol Macromol; 2020 Dec; 164():2881-2894. PubMed ID: 32853621
[TBL] [Abstract][Full Text] [Related]
33. Estrone-Decorated Polyion Complex Micelles for Targeted Melittin Delivery to Hormone-Responsive Breast Cancer Cells.
Raveendran R; Chen F; Kent B; Stenzel MH
Biomacromolecules; 2020 Mar; 21(3):1222-1233. PubMed ID: 32022540
[TBL] [Abstract][Full Text] [Related]
34. Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo.
Thai H; Thuy Nguyen C; Thi Thach L; Thi Tran M; Duc Mai H; Thi Thu Nguyen T; Duc Le G; Van Can M; Dai Tran L; Long Bach G; Ramadass K; Sathish CI; Van Le Q
Sci Rep; 2020 Jan; 10(1):909. PubMed ID: 31969608
[TBL] [Abstract][Full Text] [Related]
35. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer statistics, 2019.
DeSantis CE; Ma J; Gaudet MM; Newman LA; Miller KD; Goding Sauer A; Jemal A; Siegel RL
CA Cancer J Clin; 2019 Nov; 69(6):438-451. PubMed ID: 31577379
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
39. Tutorial on Powder X-ray Diffraction for Characterizing Nanoscale Materials.
Holder CF; Schaak RE
ACS Nano; 2019 Jul; 13(7):7359-7365. PubMed ID: 31336433
[No Abstract] [Full Text] [Related]
40. Acidic pH and High-H
Lin B; Chen H; Liang D; Lin W; Qi X; Liu H; Deng X
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11157-11166. PubMed ID: 30869853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
